Compound loss of muscleblind-like function in myotonic dystrophy

Kuang Yung Lee, Moyi Li, Mini Manchanda, Ranjan Batra, Konstantinos Charizanis, Apoorva Mohan, Sonisha A. Warren, Christopher M. Chamberlain, Dustin Finn, Hannah Hong, Hassan Ashraf, Hideko Kasahara, Laura P.W. Ranum, Maurice S. Swanson*

*此作品的通信作者

研究成果: 期刊稿件文章同行評審

144 引文 斯高帕斯(Scopus)

摘要

Myotonic dystrophy (DM) is a multi-systemic disease that impacts cardiac and skeletal muscle as well as the central nervous system (CNS). DM is unusual because it is an RNA-mediated disorder due to the expression of toxic microsatellite expansion RNAs that alter the activities of RNA processing factors, including the muscleblind-like (MBNL) proteins. While these mutant RNAs inhibit MBNL1 splicing activity in heart and skeletal muscles, Mbnl1 knockout mice fail to recapitulate the full-range of DM symptoms in these tissues. Here, we generate mouse Mbnl compound knockouts to test the hypothesis that Mbnl2 functionally compensates for Mbnl1 loss. Although Mbnl1-/-; Mbnl2-/- double knockouts (DKOs) are embryonic lethal, Mbnl1-/-; Mbnl2+/- mice are viable but develop cardinal features of DM muscle disease including reduced lifespan, heart conduction block, severe myotonia and progressive skeletal muscle weakness. Mbnl2 protein levels are elevated in Mbnl1-/- knockouts where Mbnl2 targets Mbnl1-regulated exons. These findings support the hypothesis that compound loss of MBNL function is a critical event in DM pathogenesis and provide novel mouse models to investigate additional pathways disrupted in this RNA-mediated disease.

原文英語
頁(從 - 到)1887-1900
頁數14
期刊EMBO Molecular Medicine
5
發行號12
DOIs
出版狀態已出版 - 12 2013
對外發佈

指紋

深入研究「Compound loss of muscleblind-like function in myotonic dystrophy」主題。共同形成了獨特的指紋。

引用此